Blockbuster Results from IMC’s NASH Liver Therapy Trials

Today, IMC is setting a new standard as far as ‘positive developments’ go, topline results show significant improvement in liver injury and a significant reduction in blood levels of LPS — a known mediator of liver inflammation in patients with NASH.

This category is empty! Please try another category or use our search function to find what you are looking for. If you require further assistance please contact us.